In addition, circulating FABP4 concentrations have been reported to predict the risk of CV mortality among older adults with and without established CV disease [56] and associated with the risk of sudden cardiac death in older non-T2D individuals [53]. The gene discussed is FABP4; the disease is type 2 diabetes mellitus.